Batavia Biosciences and Immutep utilize Horizon’s GS knockout CHO K1 cell line expression system to generate high yielding cell line for LAG-3 immunotherapy Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation for cell line engineering, today announced that […]
SAN DIEGO and EMERYVILLE, Calif. —Ablexis, LLC, AlivaMab Discovery Services, LLC (“ADS”) and Berkeley Lights, Inc. today announced the rapid generation and recovery of sequences encoding a rich panel of human antibodies against the S1 spike protein of the SARS-CoV-2 virus. Based on multiplex screening assays performed on the Beacon® platform, these SARS-CoV-2 S1 antibodies may be […]
The consortium led by The University of Oxford is fast-tracking clinical trials beginning in April 2020 PORT WASHINGTON, N.Y. — Pall Corporation, a global leader in filtration, separation and purification, today announced its participation in a consortium led by the Jenner Institute, University of Oxford (Oxford, England), to rapidly develop, scale-up and produce a […]
PHILADELPHIA – The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Integral Molecular $1 million to enable the application of Integral Molecular’s technology platforms to aid in the discovery of vaccines and therapeutics to combat COVID-19. Integral Molecular’s Shotgun Mutagenesis Epitope Mapping platform precisely identifies where antibodies bind to their target proteins, and will be […]
MOBILion Systems, Inc. is partnering with Drs. Lance Wells and Michael Tiemeyer, pioneering researchers at the Complex Carbohydrate Research Center (CCRC), University of Georgia, to conduct COVID-19 glycan analysis using the company’s patented SLIM (Structures for Lossless Ion Mobility) separations technology. The new project aims to detail the glycosylation microheterogeneity in the spike glycoprotein that […]
Single cell analysis for therapeutic discovery recognized with prestigious business award for innovation Cambridge, UK: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, has be honored with a Queen’s Award for Enterprise for Innovation. The award recognizes the Company’s excellence in patenting, developing and globally commercializing single cell analysis […]
HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, has extended its range of recombinant monoclonal anti-idiotypic antibodies with the introduction of antibodies that are specific for ipilimumab (Yervoy) and the ipilimumab/CTLA-4 drug-target complex. These highly specific and high-affinity antibodies are suitable for bioanalytical and […]
panCELLa and CCRM collaborate to benefit academia and industry Toronto, ON — Toronto-based panCELLa and CCRM have executed a collaboration agreement using novel technology to generate commercial-use and clinical-grade iPSC lines which will be made available to academia and industry to enable the development of new therapies. “panCELLa is an innovative company and a key […]
London, UK / MicrofluidX announces it has raised £1.4m in seed funding from leading seed investors UK Innovation & Science Seed Fund (UKI2S), Longwall Ventures and Moulton Goodies Limited with angel contributions from 88 Capital and Cambridge Angels. The Company will develop its novel cell bioprocessing technology, utilising microfluidics to tackle the challenges associated with bioprocessing for cell […]
Deployment expands access to PacBio’s highly accurate long reads on the African continent for a variety of applications, from ethnic-specific reference genomes to COVID-19 research MENLO PARK, Calif. and PRETORIA, South Africa — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, and inqaba biotec, the leading […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
